Three plastic surgeons involved with the XPAND clinical study for the AeroForm Tissue Expander System, manufactured by AirXpanders Inc, will present their experiences and results at ASPS’ upcoming Plastic Surgery: The Meeting 2016 in Los Angeles.
According to a media release from Palo Alto, Calif-headquartered AirXpanders, the following presentations will take place:
• Friday, September 23: Dr Kamakshi Zeidler (Los Gatos, Calif.) will provide clinicians a primer on AeroForm at the Hot Topics in Plastic Surgery session.
• Friday, September 23: Dr Khashayar Mohebali (Marin County, Calif) will present information detailing the use of AeroForm and clinical results to plastic surgery residents at the Resident’s Day Program.
• Monday, September 26: Dr Jeffrey Ascherman (Columbia University, New York) will present the results of AirXpanders’ XPAND US pivotal trial, a prospective, multi-center, randomized, controlled study which compared AeroForm to saline tissue expansion, at a Scientific Abstracts session.
“Drs Ascherman, Zeidler, and Mohebali have all played a critical role in advancing the clinical understanding of AeroForm, and we are delighted these leaders can share their experiences with their esteemed peers at such an important time for the company,” says Scott Dodson, president and CEO of AirXpanders Inc.
“We look forward to educating the plastic surgery community on this revolutionary technology that could change the standard of care for two-stage breast reconstruction,” he adds.
[Source(s): AirXpanders Inc, PR Newswire]